The Latest Analyst Ratings For Ionis Pharmaceuticals
The Latest Analyst Ratings For Ionis Pharmaceuticals
ionis pharmaceuticals的最新分析師評級
The perception of Ionis Pharmaceuticals by...Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Ionis Pharmaceuticals (NASDAQ:IONS) in the last three months.
在過去的三個月裏，共有6位分析師就Ionis Pharmaceuticals (NASDAQ:IONS)提供看好至看淡的多元化觀點。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況，突出了過去30天內情緒的變化，並將其與之前的月份進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $66.17, a high estimate of $82.00, and a low estimate of $53.00. Marking an increase of 14.09%, the current average surpasses the previous average price target of $58.00.
分析師們分析了12個月的價值目標，平均目標爲$66.17，最高估值爲$82.00，最低估值爲$53.00。當前的平均價值較之前的平均價值$58.00增加了14.09%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
The perception of Ionis Pharmaceuticals by...
專業人士對I...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間